Clinical Trials Logo

Filter by:
NCT ID: NCT05724095 Completed - Clinical trials for Hypotension During Surgery

Electrical Acupoint Stimulation Reduces Intrathecal Anesthesia Induced Hypotension

EARTH
Start date: February 20, 2023
Phase: N/A
Study type: Interventional

The parturients may suffer from hypotension after spinal anesthesia and the incidence could be as high as 70-80% when pharmacological prophylaxis is not used. Acupuncture was reported to treat hypotension both in human and animal studies. Possible mechanisms include modulating cardiovascular and sympathetic system. In this prospective, double-blinded, randomized clinical trial, we tend to investigate the effect of transcutaneous electric acupoint stimulation (TEAS) on hypotension in parturients undergoing cesarean section.

NCT ID: NCT05723991 Recruiting - Clinical trials for Urothelial Carcinoma

Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma

Start date: September 28, 2022
Phase: Phase 4
Study type: Interventional

A multicenter, open, single arm, phase II clinical trial was designed for myometrial invasive bladder cancer to evaluate the efficacy and safety of RC48-ADC combined with gemcitabine in preoperative neoadjuvant treatment of MIBC, and provide high-level clinical evidence for gemcitabine combined with ADC in the treatment of MIBC

NCT ID: NCT05723978 Completed - Clinical trials for Carcinoma, Pancreatic Ductal

Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.

Start date: January 1, 2011
Phase:
Study type: Observational

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with relatively poor survival. Surgery is the first choice for the treatment of patients with early pancreatic cancer. However, the surgical approach and the extent of resection for patients with pancreatic cancer are controversial at present. The investigators optimized the procedure of standard pancreaticoduodenectomy to selective extended dissection (SED), which is based on the extra-pancreatic nerve plexus (PLX) potentially invaded by tumor. The investigators retrospectively analyzed the clinicopathological data of patients with pancreatic adenocarcinoma who underwent radical surgery in our center from 2011 to 2020. Patients who underwent standard dissection (SD) were matched 2:1 to those who underwent SED using propensity score matching (PSM). The log-rank test and cox regression model were used to analyze survival data. In addition, statistical analyses were performed for the perioperative complications, postoperative pathology and recurrence pattern.

NCT ID: NCT05723731 Recruiting - Clinical trials for Chronic Constipation

Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Chronic Constipation

Start date: January 3, 2023
Phase: N/A
Study type: Interventional

The worldwide prevalence of chronic constipation (CC) is 15%, and women are more likely to develop the disease than men. CC have a significant impact on quality of life and increase the burden of national health insurance. The conventional medication treatments are primarily symptom-specific and have limited efficacy. Previous small sample study had shown the therapeutic potential of transcutaneous auricular vagus nerve stimulation (taVNS) for irritable bowel syndrome with constipation (IBS-C). The aim of this study was to investigate whether taVNS could improve defecation condition and constipation symptoms in patients with CC.

NCT ID: NCT05723432 Recruiting - Melanoma Clinical Trials

KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma

Start date: March 22, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1b/2, open label study to evaluate the safety, tolerability, pharmacokinetics and initial efficacy of KD6001 in combination with toripalimab in patients with advanced melanoma.

NCT ID: NCT05723263 Recruiting - Gonorrhea Clinical Trials

Pay-it-forward Gonorrhea and Chlamydia Testing Among Men in China

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

PIONEER is a three-arm, programmatic cluster randomized controlled trial (RCT) to compare effectiveness of three implementation strategies, followed by a mixed-methods implementation evaluation study

NCT ID: NCT05723003 Recruiting - Pulmonary Embolism Clinical Trials

Prospective Validation of an Acute Pulmonary Embolism Severity and Prognosis Prediction Model

Start date: February 1, 2023
Phase:
Study type: Observational

The purpose of this study is to prospectively validate the first PUMCH model for acute PE severity and prognosis prediction based on multi-center data constructed in the pre-project period based on national population data, and to optimize the PUMCH model based on artificial intelligence clustering algorithm.

NCT ID: NCT05722964 Recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis

Start date: March 29, 2023
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of intravenous SHR-1906 in the treatment of idiopathic pulmonary fibrosis. The study is divided into four stages: screening period, baseline period, treatment period and safe follow-up period. It is planned that 108 patients will be randomly assigned to the following three treatment groups for treatment

NCT ID: NCT05722405 Recruiting - Multiple Myeloma Clinical Trials

Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma

Start date: July 1, 2022
Phase: Phase 4
Study type: Interventional

This study was designed to investigate whether the oral proteasome inhibitor ixazomib combined with low-dose lenalidomide(10mg) as a maintenance regimen could improve the outcome and prognosis of patients with high-risk multiple myeloma after induction and consolidation of VRD-based regimen.

NCT ID: NCT05722392 Recruiting - Prostate Cancer Clinical Trials

Safety and Efficacy of Two-step Radical Prostatectomy

Start date: February 15, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about the safety and efficacy of two-step radical prostatectomy in the treatment of low- to intermediate-risk prostate cancer patient with enlarged prostate and severe benign prostatic hyperplasia. The main question it aims to answer are: 1. Whether two-step prostatectomy is safe enough to decrease the surgical difficulty of these patients? 2. Whether the oncologic control is promising?